Intellectual Property & Patents

University Collaboration & Patent Development

GreenWay’s intellectual property portfolio originates from a university research collaboration established in 2016. In 2019, research from this collaboration resulted in the filing of a patent application by Middle Tennessee State University (MTSU). The intellectual property was later assigned to GreenWay Herbal Products, LLC in 2022, to pursue US and international patents.

Patents have been awarded in the United Kingdom (GB 2597163) and (GB 2614634) in 2023, in the United States (US 12496307) in 2025, and we are actively defending patents in multiple other counties.

Cannabinoid Compositions and Methods of Using

Issued Patents

• United Kingdom (2023)

  • GB 2597163

  • GB 2614634

• United States (2025)

  • US 12,496,307

Pending Patent Applications

• Canada (CA 3132856)

• European Union (EP 3962296)

• Israel (IL 318621)

• Thailand

Additional Patent Applications

• Cannabinoid and omega fatty acid compositions and methods of use

Looking Forward

GreenWay Herbal Products continues to invest in cannabinoid research with the intent to expand its intellectual property estate and, subject to regulatory pathways, pursue future clinical development opportunities. Our strategy balances near-term commercialization through licensed consumer brands with long-term pharmaceutical and therapeutic innovation grounded in defensible science and issued patents.

[updated: 01/07/2026]